Details about Elias Mossialos

Access statistics for papers by Elias Mossialos.

Last updated 2024-11-17. Update your information in the RePEc Author Service.

Short-id: pmo1510

Working Papers

2023

1. COVID-19 anti-contagion policies and economic support measures in the USA
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (2)
   See also Journal Article COVID-19 anti-contagion policies and economic support measures in the USA, Oxford Economic Papers, Oxford University Press (2023) View citations (2) (2023)
2. Evaluation of the NHS England evidence based interventions programme: a difference-in-difference analysis
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library
3. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
   Open Access Publications from Kiel Institute for the World Economy, Kiel Institute for the World Economy (IfW Kiel) View citations (1)

2021

4. Effectiveness of Government Policies in Response to the COVID-19 Outbreak
   Discussion Paper Series, Department of Economics, University of Macedonia View citations (9)
5. End-of-life planning depends on socio-economic and racial background: evidence from the US Health and Retirement Study (HRS)
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library
6. Securing a sustainable and fit-for-purpose UK health and care workforce
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (3)
7. Social and physical environment disparities contribute to mortality outcomes during the COVID-19 pandemic in the United States
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library
8. What is the right level of spending needed for health and care in the UK?
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (3)

2020

9. The Netflix plus model: Can subscription financing improve access to medicines in low- And middle-income countries?
   LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library
   See also Journal Article The ‘Netflix plus model’: can subscription financing improve access to medicines in low- and middle-income countries?, Health Economics, Policy and Law, Cambridge University Press (2021) (2021)

2019

10. Does economic recession impact newborn health? Evidence from Greece
    LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (9)
    See also Journal Article Does economic recession impact newborn health? Evidence from Greece, Social Science & Medicine, Elsevier (2019) View citations (12) (2019)
11. Health and social care
    CEP Election Analysis Papers, Centre for Economic Performance, LSE View citations (1)
12. Performance of UK National Health Service compared with other high income countries: observational study
    LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (7)
13. Self-reported symptoms of depression among Chinese rural-to-urban migrants and left-behind family members
    LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (2)

2017

14. Global health financing towards 2030 and beyond
    LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library
15. Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps
    LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (3)

2016

16. A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility
    LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (1)

2015

17. Timely publication and sharing of trial data: opportunities and challenges for comparative effectiveness research in cardiovascular disease
    LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library

2006

18. Bioethical Implications of Globalization: An International Consortium Project of the European Commission
    University of California at San Francisco, Center for Tobacco Control Research and Education, Center for Tobacco Control Research and Education, UC San Francisco
    See also Journal Article Bioethical Implications of Globalization: An International Consortium Project of the European Commission, PLOS Medicine, Public Library of Science (2006) (2006)

2003

19. The regulation of pharmacies in six countries: report prepared for the Office of Fair Trading
    LSE Research Online Documents on Economics, London School of Economics and Political Science, LSE Library View citations (5)

Journal Articles

2023

1. Accelerating integration of social needs into mainstream healthcare to achieve health equity in the COVID-19 era
   Health Economics, Policy and Law, 2023, 18, (1), 82-87
2. COVID-19 anti-contagion policies and economic support measures in the USA
   Oxford Economic Papers, 2023, 75, (3), 613-630 View citations (2)
   See also Working Paper COVID-19 anti-contagion policies and economic support measures in the USA, LSE Research Online Documents on Economics (2023) View citations (2) (2023)
3. The impact of collaborative organisational models and general practice size on patient safety and quality of care in the English National Health Service: A systematic review
   Health Policy, 2023, 138, (C)
4. The launch of the EU Health Emergency Preparedness and Response Authority (HERA): Improving global pandemic preparedness?
   Health Policy, 2023, 133, (C)

2022

5. Clinical negligence cases in the English NHS: uncertainty in evidence as a driver of settlement costs and societal outcomes
   Health Economics, Policy and Law, 2022, 17, (3), 266-281
6. Drawing light from the pandemic: Rethinking strategies for health policy and beyond
   Health Policy, 2022, 126, (1), 1-6 View citations (4)
7. Effectiveness of government policies in response to the first COVID-19 outbreak
   PLOS Global Public Health, 2022, 2, (4), 1-19 View citations (4)
8. Promoting innovation while controlling cost: The UK's approach to health technology assessment
   Health Policy, 2022, 126, (3), 224-233

2021

9. COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
   Health Policy, 2021, 125, (5), 553-567 View citations (23)
10. Evaluation of progress toward universal health coverage in Myanmar: A national and subnational analysis
    PLOS Medicine, 2021, 18, (10), 1-18
11. Financial protection in health among the middle-aged and elderly: Evidence from the Greek economic recession
    Health Policy, 2021, 125, (9), 1256-1266 View citations (1)
12. The EU Response to COVID‐19: From Reactive Policies to Strategic Decision‐Making
    Journal of Common Market Studies, 2021, 59, (S1), 56-68 View citations (2)
13. The impact of primary health care and specialist physician supply on amenable mortality in Mexico (2000–2015): Panel data analysis using system-Generalized Method of Moments
    Social Science & Medicine, 2021, 278, (C) View citations (4)
14. The ‘Netflix plus model’: can subscription financing improve access to medicines in low- and middle-income countries?
    Health Economics, Policy and Law, 2021, 16, (2), 113-123
    See also Working Paper The Netflix plus model: Can subscription financing improve access to medicines in low- And middle-income countries?, LSE Research Online Documents on Economics (2020) (2020)

2020

15. 12 Lessons learned from the management of the coronavirus pandemic
    Health Policy, 2020, 124, (6), 577-580 View citations (27)
16. Association between provincial income levels and drug prices in China over the period 2010–2017
    Social Science & Medicine, 2020, 263, (C)
17. Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US
    Social Science & Medicine, 2020, 258, (C) View citations (2)

2019

18. Assessment of Devices, Diagnostics and Digital Technologies: A Review of NICE Medical Technologies Guidance
    Applied Health Economics and Health Policy, 2019, 17, (2), 189-211 View citations (1)
19. Does economic recession impact newborn health? Evidence from Greece
    Social Science & Medicine, 2019, 237, (C), - View citations (12)
    See also Working Paper Does economic recession impact newborn health? Evidence from Greece, LSE Research Online Documents on Economics (2019) View citations (9) (2019)
20. The impact of the Greek economic adjustment programme on household health expenditure
    Social Science & Medicine, 2019, 222, (C), 274-284 View citations (5)

2018

21. An ethical appraisal of living-anonymous kidney donation using Adam Smith’s Theory of Moral Sentiments
    Health Policy, 2018, 122, (11), 1212-1221

2017

22. Crowdfunding our health: Economic risks and benefits
    Social Science & Medicine, 2017, 191, (C), 48-56 View citations (13)
23. Does health insurance reduce out-of-pocket expenditure? Heterogeneity among China's middle-aged and elderly
    Social Science & Medicine, 2017, 190, (C), 11-19 View citations (14)
24. Health policy in times of austerity—A conceptual framework for evaluating effects of policy on efficiency and equity illustrated with examples from Europe since 2008
    Health Policy, 2017, 121, (9), 947-954 View citations (8)

2016

25. A comparative study of drug listing recommendations and the decision-making process in Australia, the Netherlands, Sweden, and the UK
    Health Policy, 2016, 120, (10), 1104-1114 View citations (9)
26. Pharmaceutical pricing and reimbursement in China: When the whole is less than the sum of its parts
    Health Policy, 2016, 120, (5), 519-534 View citations (12)
27. Systems, not pills: The options market for antibiotics seeks to rejuvenate the antibiotic pipeline
    Social Science & Medicine, 2016, 151, (C), 167-172 View citations (1)

2015

28. From “retailers” to health care providers: Transforming the role of community pharmacists in chronic disease management
    Health Policy, 2015, 119, (5), 628-639 View citations (18)

2014

29. Mapping support policies for informal carers across the European Union
    Health Policy, 2014, 118, (1), 84-94 View citations (27)

2013

30. Expanding the role of community pharmacists: Policymaking in the absence of policy-relevant evidence?
    Health Policy, 2013, 111, (2), 135-148 View citations (9)

2012

31. Balancing economic freedom against social policy principles: EC competition law and national health systems
    Health Policy, 2012, 106, (2), 127-137 View citations (2)
32. Behavioral adjustment to avian flu in Europe during spring 2006: The roles of knowledge and proximity to risk
    Social Science & Medicine, 2012, 75, (8), 1362-1371 View citations (1)

2011

33. Equity in health care use among older people in the UK: an analysis of panel data
    Applied Economics, 2011, 43, (18), 2229-2239 View citations (11)
34. The Impact of Alcohol Policies across Europe on Young Adults' Perceptions of Alcohol Risks
    CESifo Economic Studies, 2011, 57, (4), 763-788 View citations (1)

2009

35. Measuring socioeconomic differences in use of health care services by wealth versus by income
    American Journal of Public Health, 2009, 99, (10), 1849-1855 View citations (21)
36. Optimism and the perceptions of new risks
    Journal of Risk Research, 2009, 12, (1), 27-41 View citations (15)
37. When is the Internet a valued communication device for health information in Europe?
    Economics of Innovation and New Technology, 2009, 18, (5), 429-445 View citations (3)

2008

38. A Conceptual Framework for Community-Based Health Insurance in Low-Income Countries: Social Capital and Economic Development
    World Development, 2008, 36, (4), 590-607 View citations (20)
39. Attitudes as an Expression of Knowledge and “Political Anchoring”: The Case of Nuclear Power in the United Kingdom
    Risk Analysis, 2008, 28, (5), 1273-1288 View citations (10)

2007

40. A pricing policy towards the sourcing of cheaper drugs in Cyprus
    Health Policy, 2007, 81, (2-3), 368-375 View citations (6)

2006

41. Bioethical Implications of Globalization: An International Consortium Project of the European Commission
    PLOS Medicine, 2006, 3, (2), 1-
    See also Working Paper Bioethical Implications of Globalization: An International Consortium Project of the European Commission, University of California at San Francisco, Center for Tobacco Control Research and Education (2006) (2006)
42. Erring on the Side of Caution? The Heterogeneity of Public Perceptions of Biotechnology Applications in the European Union
    Journal of Economic Issues, 2006, 40, (3), 767-777
43. Pharmaceutical Pricing in Europe: Weighing up the Options
    International Social Security Review, 2006, 59, (3), 3-25 View citations (5)
44. The Public as a Limit to Technology Transfer: The Influence of Knowledge and Beliefs in Attitudes towards Biotechnology in the UK
    The Journal of Technology Transfer, 2006, 31, (6), 629-645 View citations (6)
45. Which policies effectively enable smoking cessation? Evidence from the European Union
    International Journal of Social Economics, 2006, 33, (1), 77-100 View citations (2)

2005

46. Analysing the Greek health system: a tale of fragmentation and inertia
    Health Economics, 2005, 14, (S1), S151-S168 View citations (33)
47. Is dread of Genetically Modified food associated with the consumers' demand for information?
    Applied Economics Letters, 2005, 12, (14), 859-863 View citations (8)
48. Is there 'patient selection' in the demand for private maternity care in Greece?
    Applied Economics Letters, 2005, 12, (1), 7-12 View citations (3)
49. The contestable nature of health policy analysis
    Health Economics, 2005, 14, (S1), S3-S6 View citations (1)

2003

50. Stimulating pharmaceutical research and development for neglected diseases
    Health Policy, 2003, 64, (1), 75-88 View citations (9)
51. The European Court of Justice and the free movement of patients in the European Union
    International Social Security Review, 2003, 56, (2), 3-29

2002

52. The European Union and Health Policy, by Ed Randall. Palgrave, Hampshire and New York, 2001. No. of pages: xiii+278. ISBN 0‐333‐75426‐3.. The Implications of Recent Jurisprudence on the Co‐ordination of Health Care Protection Systems, by Willy Palm, Jason Nickless, Henri Lewalle and Alain Coheur. Association Internationale de la Mutualite, Brussess, 2000. No. of pages: 170. [http://europa.eu.int/comm/employment_social/soc‐prot/disable/report.pdf]. Health Care Without Frontiers? The Development of a European Market in Health Services by Lyndsay Mountford. Office of Health Econ‐omics, London, 2000. No. of pages: 83. ISBN 1‐899040‐71‐4
    Health Economics, 2002, 11, (3), 281-284

2000

53. Has the Portuguese NHS Achieved its Objectives of Equity and Efficiency?
    International Social Security Review, 2000, 53, (4), 49-78 View citations (6)

1999

54. Citizens and rationing: analysis of a European survey
    Health Policy, 1999, 49, (1-2), 75-135 View citations (18)

1997

55. Citizens' Views on Health Care Systems in the 15 Member States of The European Union
    Health Economics, 1997, 6, (2), 109-116 View citations (26)
56. Erratum to Will Managed Care Work in Europe?
    PharmacoEconomics, 1997, 11, (6), 594-594

1994

57. Cost containment and health care reform: a study of the European Union
    Health Policy, 1994, 28, (2), 89-132 View citations (26)

Edited books

2010

1. Performance Measurement for Health System Improvement
   Cambridge Books, Cambridge University Press
2. Performance Measurement for Health System Improvement
   Cambridge Books, Cambridge University Press